Intrinsic Value of S&P & Nasdaq Contact Us

Johnson & Johnson JNJ NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
73/100
4/7 Pass
SharesGrow Intrinsic Value
$268.06
+11.6%
Analyst Price Target
$228.73
-4.7%

Stock Statistics — JNJ

Johnson & Johnson (JNJ) has a market capitalization of $578.62B and trades at $240.10. The 52-week range is 141.5-251.71.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 21.8, Earnings Per Share (EPS) of $11.03, annual revenue of $94.19B.

The stock has a beta of 0.33, a last dividend of $5.2000, operates in the Healthcare sector.

Trading Data
Current Price$240.10
52-Week Range141.5-251.71
Volume9.35M
Avg Volume (30D)8.63M
Market Cap$578.62B
Beta (1Y)0.33
Last Dividend$5.2000
Company
IPO Date1943-01-02
Employees138,100
CEOJoaquin Duato
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS4781601046
CUSIP478160104
Income (Latest Year)
Revenue$94.19B
Gross Profit$68.56B
EBITDA$39.9B
Operating Income$25.6B
Net Income$26.8B
EPS$11.03
EPS Diluted$11.03
Shares Outstanding$2.43B
Balance Sheet (Latest Year)
Total Assets$199.21B
Current Assets$55.62B
Cash & ST Investments$20.1B
Total Liabilities$117.67B
Total Debt$47.93B
Net Debt$28.22B
Total Equity$81.54B
Debt / Equity0.59
Valuation Ratios
P/E Ratio21.8
P/S Ratio6.14
P/B Ratio7.1
EV/EBITDA (approx)14.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message